Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Language English Country Great Britain, England Media electronic
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
Grant support
CA128978
NCI NIH HHS - United States
03/DHCS/03/G121/51
Department of Health - United Kingdom
U01 CA69417
NCI NIH HHS - United States
R01CA64277
NCI NIH HHS - United States
RFA-CA-06-503
NCI NIH HHS - United States
P30 CA68485
NCI NIH HHS - United States
R01 CA148667
NCI NIH HHS - United States
C1287/A12014
Cancer Research UK - United Kingdom
R01 CA77398
NCI NIH HHS - United States
CA132839
NCI NIH HHS - United States
CA098758
NCI NIH HHS - United States
001
World Health Organization - International
CA54281
NCI NIH HHS - United States
MR/K006215/1
Medical Research Council - United Kingdom
16563
Cancer Research UK - United Kingdom
10124
Cancer Research UK - United Kingdom
CA116201
NCI NIH HHS - United States
5U01CA098216-07
NCI NIH HHS - United States
R01 CA092447
NCI NIH HHS - United States
R01CA148667
NCI NIH HHS - United States
C8197/A10123
Cancer Research UK - United Kingdom
CA63464
NCI NIH HHS - United States
C490/A10124
Cancer Research UK - United Kingdom
U01 CA116167
NCI NIH HHS - United States
R01CA100374
NCI NIH HHS - United States
CA116167
NCI NIH HHS - United States
R37CA70867
NCI NIH HHS - United States
P50 CA116201
NCI NIH HHS - United States
16565
Cancer Research UK - United Kingdom
NF-SI-0512-10122
Department of Health - United Kingdom
N01CN25403
NCI NIH HHS - United States
090532
Wellcome Trust - United Kingdom
16561
Cancer Research UK - United Kingdom
CRN-87521
CIHR - Canada
R01 CA077398
NCI NIH HHS - United States
U01 CA69638
NCI NIH HHS - United States
Intramural NIH HHS - United States
C1287/A10118
Cancer Research UK - United Kingdom
U01 CA69467
NCI NIH HHS - United States
PubMed
24887515
PubMed Central
PMC4522594
DOI
10.1186/bcr3662
PII: bcr3662
Knihovny.cz E-resources
- MeSH
- White People MeSH
- Cytochrome P-450 CYP3A genetics MeSH
- Adult MeSH
- Genetic Predisposition to Disease MeSH
- Genetic Association Studies * MeSH
- Genotype MeSH
- Polymorphism, Single Nucleotide MeSH
- Middle Aged MeSH
- Humans MeSH
- Menarche genetics MeSH
- Breast Neoplasms genetics pathology MeSH
- Premenopause genetics MeSH
- Reproductive History MeSH
- Risk Factors MeSH
- Aged MeSH
- Age of Onset MeSH
- Age Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, N.I.H., Intramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Names of Substances
- Cytochrome P-450 CYP3A MeSH
INTRODUCTION: We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with a reduction in premenopausal urinary estrone glucuronide levels and a modest reduction in risk of breast cancer in women age ≤50 years. METHODS: We further investigated the association of rs10235235 with breast cancer risk in a large case control study of 47,346 cases and 47,570 controls from 52 studies participating in the Breast Cancer Association Consortium. Genotyping of rs10235235 was conducted using a custom Illumina Infinium array. Stratified analyses were conducted to determine whether this association was modified by age at diagnosis, ethnicity, age at menarche or tumor characteristics. RESULTS: We confirmed the association of rs10235235 with breast cancer risk for women of European ancestry but found no evidence that this association differed with age at diagnosis. Heterozygote and homozygote odds ratios (ORs) were OR = 0.98 (95% CI 0.94, 1.01; P = 0.2) and OR = 0.80 (95% CI 0.69, 0.93; P = 0.004), respectively (P(trend) = 0.02). There was no evidence of effect modification by tumor characteristics. rs10235235 was, however, associated with age at menarche in controls (P(trend) = 0.005) but not cases (P(trend) = 0.97). Consequently the association between rs10235235 and breast cancer risk differed according to age at menarche (P(het) = 0.02); the rare allele of rs10235235 was associated with a reduction in breast cancer risk for women who had their menarche age ≥15 years (OR(het) = 0.84, 95% CI 0.75, 0.94; OR(hom) = 0.81, 95% CI 0.51, 1.30; P(trend) = 0.002) but not for those who had their menarche age ≤11 years (OR(het) = 1.06, 95% CI 0.95, 1.19, OR(hom) = 1.07, 95% CI 0.67, 1.72; P(trend) = 0.29). CONCLUSIONS: To our knowledge rs10235235 is the first single nucleotide polymorphism to be associated with both breast cancer risk and age at menarche consistent with the well-documented association between later age at menarche and a reduction in breast cancer risk. These associations are likely mediated via an effect on circulating hormone levels.
Cancer Prevention Institute of California 2201 Walnut Avenue Suite 300 Fremont California 95438 USA
Channing Division of Network Medicine Harvard Medical School 181 Longwood Avenue Boston MA 02115 USA
Cogentech Cancer Genetic Test Laboratory IFOM IEO Campus Via Adamello16 20139 Milan Italy
College of Public Health China Medical University No 91 Hsueh Shih Road Taichung 40402 Taiwan
Dana Farber Harvard Cancer Center 450 Brookline Ave Boston MA 02215 USA
Department of Epidemiology Harvard School of Public Health 677 Huntington Avenue Boston MA 02115 USA
Department of Genetics and Pathology Pomeranian Medical University Rybacka 1 70 204 Szczecin Poland
Department of Health Sciences Research Mayo Clinic 200 1st Street SW Rochester MN 55905 USA
Department of Oncology Oulu University Hospital University of Oulu Kajaanintie 50 90220 Oulu Finland
Department of Radiation Oncology Hannover Medical School Carl Neuberg Str 1 30625 Hannover Germany
Department of Surgery Oulu University Hospital University of Oulu Kajaanintie 50 90220 Oulu Finland
Faculty of Medicine University of Oslo Sogn Arena Klaus Torgårds vei 3 2 etg 0372 Oslo Norway
Frauenklinik der Stadtklinik Baden Baden Balger Strasse 50 76532 Baden Württemberg Germany
German Cancer Consortium Im Neuenheimer Feld 280 69121 Heidelberg Germany
Human Genetics Division Genome Institute of Singapore 60 Biopolis St Singapore 138672 Singapore
IFOM Fondazione Istituto FIRC di Oncologia Molecolare Via Adamello 16 20139 Milan Italy
Inserm U1018 Environmental Epidemiology of Cancer 101 rue de Tolbiac Villejuif 75654 Paris France
Institute of Biomedical Sciences Academia Sinica 2 Academia Road Nankang Taipei 115 Taiwan
Institute of Pathology Städtisches Klinikum Karlsruhe Moltkestrasse 90 76133 Karlsruhe Germany
International Agency for Research on Cancer 150 Cours Albert Thomas 69372 Lyon CEDEX 08 France
International Epidemiology Institute 1455 Research Blvd Rockville MD 20850 USA
Multidisciplinary Breast Center University Hospital Gasthuisberg Herestraat 49 3000 Leuven Belgium
N N Alexandrov Research Institute of Oncology and Medical Radiology 223040 p Lesnoy Minsk Belarus
National Cancer Institute 268 1 Rama 6 Road Rajathevi Bangkok 10400 Thailand
National University Health System 1E Kent Ridge Road Singapore 119228 Singapore
Ontario Cancer Genetics Network 620 University Avenue Toronto Ontario M5G 2L7 Canada
Sanquin Radboud Universiteit Nijmegen 6525 GA Nijmegen The Netherlands
Seoul National University College of Medicine Yongeon 103 Daehangno Jongno gu Seoul 110 799 Korea
The Academic Department of Biochemistry The Royal Marsden Hospital Fulham Road London SW3 6JJ UK
University of Tübingen Geschwister Scholl Platz 72074 Tübingen Germany
University Paris Sud UMRS 1018 101 rue de Tolbiac Villejuif 75654 Paris France
Warwick Medical School University of Warwick Coventry CV4 7AJ UK
Welcome Trust Centre for Human Genetics University of Oxford Roosevelt Drive Oxford OX3 7BN UK
See more in PubMed
Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358:1389–1399. PubMed
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85. doi: 10.1056/NEJM200007133430201. PubMed DOI
Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet. 2000;26:411–414. doi: 10.1038/82533. PubMed DOI
Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31:33–36. doi: 10.1038/ng853. PubMed DOI
Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M, van der Luijt RB. et al.Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45:353–361. doi: 10.1038/ng.2563. PubMed DOI PMC
Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, Brauch H, Chang-Claude J, Carpenter J, Godwin AK, Nevanlinna H, Giles GG, Cox A, Hopper JL, Bolla MK, Wang Q, Dennis J, Dicks E, Howat WJ, Schoof N, Bojesen SE. et al.Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet. 2013;45:392–398. doi: 10.1038/ng.2561. PubMed DOI PMC
Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst. 2004;96:936–945. doi: 10.1093/jnci/djh167. PubMed DOI
Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606–616. doi: 10.1093/jnci/94.8.606. PubMed DOI
Walker K, Bratton DJ, Frost C. Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer. 2011;105:1451–1457. doi: 10.1038/bjc.2011.358. PubMed DOI PMC
Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses’ Health Study II. Breast Cancer Res. 2013;15:R19. doi: 10.1186/bcr3394. PubMed DOI PMC
Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994;18:79–85. PubMed
Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol. 1987;125:791–799. PubMed
Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol. 1994;140:518–525. PubMed
Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer. 1997;75:1075–1079. doi: 10.1038/bjc.1997.183. PubMed DOI PMC
Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev. 2000;9:575–579. PubMed
Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, de Mesquita HB B, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A. et al.Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) J Natl Cancer Inst. 2005;97:755–765. doi: 10.1093/jnci/dji132. PubMed DOI
Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006;98:1406–1415. doi: 10.1093/jnci/djj376. PubMed DOI
Stone J, Folkerd E, Doody D, Schroen C, Treloar SA, Giles GG, Pike MC, English DR, Southey MC, Hopper JL, Dowsett M. Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study. J Clin Endocrinol Metab. 2009;94:4793–4800. doi: 10.1210/jc.2009-0713. PubMed DOI
Johnson N, Walker K, Gibson LJ, Orr N, Folkerd E, Haynes B, Palles C, Coupland B, Schoemaker M, Jones M, Broderick P, Sawyer E, Kerin M, Tomlinson IP, Zvelebil M, Chilcott-Burns S, Tomczyk K, Simpson G, Williamson J, Hillier SG, Ross G, Houlston RS, Swerdlow A, Ashworth A, Dowsett M, Peto J, Dos Santos Silva I, Fletcher O. CYP3A variation, premenopausal estrone levels, and breast cancer risk. J Natl Cancer Inst. 2012;104:657–669. doi: 10.1093/jnci/djs156. PubMed DOI
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557. PubMed DOI PMC
Dvornyk V, Waqar ul H. Genetics of age at menarche: a systematic review. Hum Reprod Update. 2012;18:198–210. doi: 10.1093/humupd/dmr050. PubMed DOI
He C, Murabito JM. Genome-wide association studies of age at menarche and age at natural menopause. Mol Cell Endocrinol. 2014;382:767–779. doi: 10.1016/j.mce.2012.05.003. PubMed DOI
Colditz GA, Baer HJ, Tamimi RM. In: Cancer Epidemiology and Prevention. 3. Schottenfeld D, Fraumeni JF, editor. New York: Oxford University Press Inc; 2006. Breast cancer; pp. 995–1011.
Prescott J, Thompson DJ, Kraft P, Chanock SJ, Audley T, Brown J, Leyland J, Folkerd E, Doody D, Hankinson SE, Hunter DJ, Jacobs KB, Dowsett M, Cox DG, Easton DF, De Vivo I. Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women. PLoS One. 2012;7:e37815. doi: 10.1371/journal.pone.0037815. PubMed DOI PMC